Trial intelligence / Profile preview

Pemetrexed and Cisplatin in Advanced Cervical Cancer

NCT00691301Phase 2Completed

Sponsor
GOG Foundation
Start
Sep 2008
Primary completion
Jul 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of pemetrexed in Cervical Cancer (CC), sponsored by GOG Foundation. Started Sep 2008; status: completed.

02

Drugs

pemetrexed
03

Conditions

Cervical Cancer (CC)

Beyond the preview

Go deeper on NCT00691301.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00691301.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call